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Vascularized first set human skin allografts were re-
jected largely by a process of extensive and progressive 
microvascular damage leading to ischemia and infarc-
tion. Microvascular injury was associated with a cellular 
immune response. However, vessel damage was at least 
in part immunologically nonspecific because vessels of 
the graft bed (host tissue) were damaged a s well as those 
of the graft itself. W e conclude that the microvascular 
endoth elium is the critical target of the immune response 
in vacularized skin allografts in man, and that this se-
quence of even ts-primary vascular damage followed by 
ischemic infarction-may have significance in a variety 
of experimental and clinical settings. 
Mononuclear cells, and especially T-lymphocytes, have an 
essential role in the rejection of vascularized grafts of normal 
tissues and of syngeneic tumors in previously unsensitized, 
genetically incompatible hosts [1-5]. However, it is not yet clear 
how these cells or their products actually effect tp·aft destruc-
tion. The leading view, originating with the classic studies of 
Medawar [1] and supported by many subsequent authors 
[2,5,6], holds that lymphocytes and other inflammatory cells 
inftltrate epithelial elements of the graft and destroy these 
target epithelial cells either by direct contact or by secretion of 
cytotoxic mediators. 
An alternate possibility proposes that the host's immune 
response is directed at least in part against the blood vessels of 
the graft which are though t to share histocompatibili ty antigens 
with epithelial cells [3,4,7]. According to this view, allografts 
are rejected as a direct consequence of vasculru· occlusion and 
tissue ischemia. This hypothesis is supported by the observation 
of intimal thickening and lymphocytic infiltration of major graft 
vessels in the course of many types of allograft rejection (re-
viewed in reference 8). However, other morphologic evidence 
of vascular injury in cell-mediated allograft rejection is less 
secure. Some authors have described widespread ·vascular 
thrombosis in skin allograft rejection [9] and from this have 
inferred a preceding endothelial lesion, but most investigators 
regard vascu lar thrombosis as a late and sporadic event in the 
rejection process. 
Not in dispute is the fact that the microvasculature plays a 
critical and generally underappreciated role in reactions of 
cellular immunity including graft rejection. It serves as the 
initial barrier which cells and proteins of the blood must tra-
verse in order to come into contact with local antigen deposits. 
Moreover, recent studies with contact allergens and purified 
proteins in both man and experimental animals have demon-
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strated that the microvasculature undergoes a number of other 
striking changes in such reactions [10,11], including local dila-
tation and increased permeability that together enhance plasma 
protein transudation; activation and proliferation of both en-
dothelial cells and pericytes; basal lamina thickening and re-
duplication; and finally, to a relatively minor extent, endothelial 
cell injury. These last findings prompted us to reexamine the 
mechanisms by which vascularized tp·afts of solid tissue were 
rejected by a primary immune response using morphological 
techniques that permitted both extensive vessel sampling and 
unequivocal evaluation of vascular endothelial cells [10,11]. In 
















F1c 1. Schematic diagram of skin allograft rejection. The graft and 
graft bed are separated by a thin layer of matted fibrin and debris 
which is bridged by blood vessels. Graft blood vessels of the papillary 
dermis (level 1) are not enveloped by cuffs of lymphocytes, whereas 
deeper graft vessels (level 2), as well as vessels of the graft bed (levels 
3 and 4), are so circumscribed. Inflammatory cells, mostly lymphocytes, 
are indicated by open circles and are concent rated about blood vessels. 
Damaged endothelial cells are colored black. Dyskeratotic foci of epi-
dermis and accompanying inflammatory cells (not separately indicated) 
are also indicated in black. Infarction of the graft after day 10 is 
designated by cross-hatching. (Fig 1-3 are reprinted, s ligh t ly alte red, 
from H . Dvorak et al [8] with the kind permission of the Editor of the 
Journal of Experimental Medicine). 
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system [12], we found that widespread microvascular damage 
p receded evidence of significant epithelial/ tumor cell necrosis 
a nd that the pattern of skin or tumor graft rejection was that 
o f ischemic infarction. These findings suggest that the endothe-
lial cells of the microvasculature are a critical target of the 
immune response and that rejection in t hese instances was 
largely attributable to extensive microvascular damage. Space 
limitations require that only t he skin allograft studies be con-
s idered here. 
MATERIALS AND METHODS 
Deta iled accounts of the procedures employed have been published 
(8]. In brief, spli t-thickness skin allografts from 2 donors were sutured 
in place in prepared sites on the deltoid surfaces of the arms of 8 adult 
male volun teers along wi th companion skin autografts. Daily punch 
biopsies were taken beginning on day 4 for study in l p.m Epon sections, 
s upplemented wit h electron microscopy and immunofluorescence [10-
12]. The design and conduct of these experiments were approved by 
t he Human Studies Committee of the Massachusetts General Hospital. 
RESULTS 
At least 3 HLA histoincompatibilities distinguished each 
recipient from his donor [8]. All recipients had a negative cross-
m atch against donor lymphocytes at the time of grafting. More-
over, recipients lacked detectable cytotoxic antibodies against 
donor lymphocytes at 7 and 15 days after transplant. After 
initial healing, all 16 allografts were sloughed between days 10 
a nd 12. By contrast, autografts healed in place and sm vived 
indefini tely. Healing of allografts and infiltration of lympho-
cyt.es and lymphoblasts about venules of the graft and graft bed 
were generally in accord with traditional descriptions as judged 
in 1 ~-tm sections (Fig 1,2A). In addit ion to demonstrating 
basophils, which complemented the lymphocytic infiltrate as in 
guinea pig allografts [13], the principal new findings concerned 
t he microvascula ture. 
T he vessels of both deeper portions of th e allograft and of 
the graft bed exhibi ted ident ical and striking alterations which 
were particularly evident in those venules and arterioles enve-
loped by cuffs of lymphocytes (Fig 1- 3). As in contact allergy 
[10,11] , pericytes and endothelial cells were hyper trophied (ac-
t ivated) and frequent ly exhibited mitoses; hypertrophied en-
dothelial cells bulged into and compromised vascular lumens. 
These findings ar e not unexpected in h ealing wounds and 
equivalent alterations were observed in parallel autografts. 
H owever, a striking new finding, not present in autografts, was 
the concomitant development of widespread and progressive 
endothelial cell injmy (Fig 2C,3) . Microscopic and ultrastruc-
tmal evidence of injmy appeared shortly after the arrival of 
perivascular lymphocyte cuffs (days 5- 6) and included endo-
thelial cell swelling and cytoplasmic lucency; membrane swell-
ing, blebbing, and disruption; nuclear pyknosis; and focal 
sloughing of entire endothelial cells, permitting exposure of 
circulating elements to the vascular basement mem brane. E n-
dothelial cell damage was often accompanied by edema, thick-
ening, and r eduplication of the basement membrane zone. 
In contrast to contact dermatit is, or delayed hypersensitivity 
to microbial antigens, where analogous microvascular injury 
was relatively sligh t and self-limited, endothelial cell .damage in 
allografts became increasingly prominent with the passage of 
t ime and progression of the cellular infiltrate (Table) . By day 
10 the vast majority of vessel profiles counted exhibited necrosis 
of at least some endothelial cells, often accompanied by per-
sistent activation of adjacent endothelial cells. Both vessels of 
the graft and recipient graft bed were affected but level 2 and 
3 vessels (defined in Fig 1) were generally damaged earlier and 
more extensively than those in levels 1 and 4. In addit ion, many 
vessel lumens were dram atically narrowed or even occluded by 
encroachment of activated or dam aged and swollen endothelial 
cells. In some instances, vessels lost their normal organization 
FIG 2. A, 8-day allograft exhibit ing extensive perivascular inflammatory cell inftl tration at level 2 of graft and levels 3 and 4 of graft bed. 
Arrows indicate t he graft- graft bed junction which is marked by trace fib rin deposits (not visible at this low magnification) and by a hair follicl e. 
T here is focal hemorrhage but lit tle lymphocyte infiltration in the superficial graft der mis and the epidermis appears intact. B, 11-day allograft 
exh ibi t ing characteristic pattern of infarction. T he desiccated graft has lost more than one-half of its vertical dimension (compare with A, 
photographed at approximately 3X lower magnifi cation) and is characterized by a necrotic epidermis (E) and prominent, dilated, and thrombosed 
blood vessels (D V). A rrows mark junction of graft and graft bed. Fibrin deposits are abundan t at junction and also extend into the graft bed, 
upper portions of which also apperu· necrotic. C, Microvasculru· endothelial cell necrosis in graft bed of an allograft undergoing immunologic 
rejection. T hree venules exhibit injury as indicated by swollen, lucent, ghost-like cell remants (V, and V 3) or by ragged loss of endothelium (V2) . 
1 p.m-thick, Giemsa-stained Epon sections (reduced from A, x 50; B, x 160; C, x 790). 
282 DVORAK ET AL Vol. 74, No.5 
FIG 3. E lectron micrograph of a typical venule from an 8-day allograft exhibit ing both endothelial cell activation (E) and necrosis (NE). Vessel 
is cuffed by small lymphocytes (Ly) (reduced from X 6,500). 
Quantitative evidence of progressive microvascular injwy preceding 
first set human shin allograft rejection" 
Allografts 
Vessel % Vessel profiles exhibi ting level necrotic endothelium 
6 day 8 day 10 day 
1 Papillary dermis, graft 30.8 42.4 76.6 
2 Deep dermis, graft 41.4 59.6 82.4 
3 Dermis, graft bed 45.0 65.5 79.8 
4 Subcutis, graft bed 34.1 40.4 45.9 
Autografts 
1 Papillary dermis, graft 0 2.7 
2 Deep dermis, graft 2.4 2.3 
3 Dermis, graft bed 3.2 0 
4 Subcutis, graft bed 0 0 
" Biopsies of 6, 8, and 10 day allografts and 8 and 10 day autografts 
were studied in 1 Jlm Epon sections. All vessels encountered at the 4 
levels indicated were scored for the presence of damaged endothelium. 
A total of 1976 allograft profiles and 360 autograft proflles were evalu-
ated. Data are expressed as the percent of vessels that exhibited one or 
more necrotic endothelial cell. Chi-square analysis revealed that in 
every instance (days 8 and 10, vessel levels 1 through 4) allograft vessels 
exhibited significantly more endothelial necrosis than corresponding 
autografts (p <0.005). 
altogether and appeared as clusters of viable or damaged but 
still identifiable (by electron microscopy) endothelial cells with-
out relating to any recognizable lumen. Larger arteries and 
veins (diameter > 50 ~tm) of the graft bed were less severely 
involved and seldom exhibited extensive lumenal narrowing but 
were occasionally infiltrated with lymphocytes or basophils. By 
day 10, thrombosis developed in some graft vessels, but the 
lumens of graft bed vessels generally remained free of fibrin 
clots despite extensive endothelial cell injury. 
The physiologic consequences of these vessel changes were 
evident as early as day 5 with the leakage of plasma from 
vessels, leading to fibrin deposition and tissue edema t hat was 
appreciated clinically as induration and swelling. After day 7 
more extensive vessel damage permitted the progressive extrav-
asation of erythrocytes from sites that could be localized in 
advantageous sections to areas of focal endothelial damage. 
These changes, which are consistent with a marked diminution 
or cessation of local blood flow, preceded widespread necrosis 
of graft epithelial elements by 24-48 hr. 
The fmal phase of the graft rejection process consisted of the 
relatively sudden (within 1-2 days) necrosis of scattered areas 
of graft tissue; these initially measured up to 1 em in largest 
SUiface dimension but coalesced ovet the subsequent 24-48 lu· 
to involve most of the graft. Microscopically (Fig 2B), such 
areas exhibited coagulation necrosis of the entire thickness of 
the graft including epidermis, a ppendages, vessels, and inflam-
matory cells, and thus resembled the type of ischemic infarction 
occuring in many other clinical settings following disruption of 
local blood flow (e.g., myocardial infarction). While necrosis 
was largely confmed to the graft itself, scattered contiguous 
portions of the superficial graft bed (tissue of recipient origin) 
were sometimes also damaged. 
The relatively sudden rejection episode could not be ex-
plained by individual anatomic contacts between the individual 
graft-epithelial elements and any type of inflammatory cell. 
While damage to epithelial cells in dyskeratotic foci of the 
epidermis and appendages may very well have been attributable 
to associations with individual cytotoxic lymphocytes, this proc-
ess was focal and progressed slowly. In fact, dyskeratotis in-
volved< 5-10% of the epithelium at the time of graft rejection. 
For purposes of comparison, autografts were studied in par-
allel with allografts. Healing of autografts resembled that of 
allografts until approximately day 5. Thereafter, autografts 
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differed from allografts in lacking both infiltration of lympho-
cytes and basophils and progressive microvasculature damage. 
In striking contrast to allografts, the vessel activation that 
accompanied healing ceased and perivascular mononuclear cell 
infiltrates and associated endothelial cell necrosis never ap-
peared in the microvasculature of either the graft or the graft 
bed. By days 10-11, autografts were well healed with a patent 
microvasculatme and healthy appearing epidermis and append-
ages. 
DISCUSSION 
The data summarized here call for a reinterpretation of 
classic mechanisms of immunologically mediated tissue destruc-
tion . In skin, as in line 1 tumor grafts [12], rejection was 
preceded and accompanied by striking damage to endothelial 
cells of the microvasculature. This microvascula1· damage af-
fected primarily and most severely those vessels cuffed by 
lymphocytes and other inflammatory cells, but anatomic con-
tacts between individual endothelial cells and inflammatory 
cells were only seldom observed. In the case of skin allografts, 
vessels putatively of host origin in the graft bed showed at least 
as much damage as those of donor origin in the graft itself, 
apparently indicating that immunologic attack was not focussed 
on vessels solely because of their content of foreign antigens. 
The microvascular changes observed in these rejecting skin 
grafts were identical to those affecting syngeneic tumor grafts 
[12], where all vessels were of host origin, and are, of comse, 
qualitatively similar to those previously described in contact 
. dermatitis and delayed hypersensitivity reactions in human 
skin [10,11]. In contrast to these last reactions, however, where 
microvascular injury was both relatively slight and self-limited, 
endothelial cell damage in rejecting skin and tumor grafts 
became increasingly prominent with time and progressed to 
involve the great majority of vessels. It seems probable, there-
fore, that the microvasculature is the critical target of immu-
nologic damage in first set human skin allografts and also in at 
least certain instances of immunologically mediated tumor de-
struction. 
The rejection process itself in both skin allografts and vas-
cularized tumor grafts resembled that of ischemic infarction. 
Consistent with this interpretation are the rapidity and pattern 
of rejection, in which extensive zones of ·erstwhile healthy-
appearing target tissue underwent sudden and simultaneous 
coagulative necrosis that was complete over a period of 1-3 
days and that for the most part did not involve contacts with 
lymphocytes or other infiltrating cells. To a pathologist, this 
pattern is typical of infarction secondary to a disruption of 
blood supply. An additional featme, peculiar to skin grafts, was 
the loss of integrity of the skin's normal function as a barrier to 
water loss, a function vested in the stratum corneum of the 
epidermis. Loss of this barrier function was manifest in the 
desiccation and shrinkage characteristic of rejecting allografts 
(Fig 2B). 
While the microvasculatw·e can now be regarded as the 
critical target in human first set skin allograft rejection, the 
mechanism(s) by which vascular endothelium is damaged re-
mains to be established. Members of the lymphocyte series 
represent the likeliest candidates for the role of effector cells, 
pa1tly because of their dominant numbers but also because of 
their striking anatomic distribution, enveloping many graft and 
graft bed vessels. If indeed these lymphocytes are responsible 
for vessel damage, a cytotoxic mechanism that does not require 
direct anatomic contacts may be implicated because endothelial 
cells were separated from enveloping inflammatory cells by the 
vascular basement membrane and sometimes by perivascular 
collagen as well. Secretion of a diffuseable mediator toxic for 
endothelial cells represents a likely possibility and the suscep-
tibility of endothelial cells to known lymphokines, such as 
lymphotoxin, deserves investigation. A role for basophils is also 
possible because of their known capacity to secrete vasoactive 
mediators such as histamine. Monocytes and macrophages, 
present in small numbers, might also be involved. 
These findings also offer an explanation for the well known 
observation that severe tuberculin and other delayed hypersen-
sitivity reactions may exhibit central necrosis; in fact, studies of 
such reactions in the guinea pig reveal a pattern of widespread 
microvascular damage and ischemic necrosis [14]. Ordinarily, 
delayed reactions do not become necrotic and exhibit only 
modest evidence of microvascular damage and repair. As long 
as repair keeps pace with injmy, tissue necrosis is unlikely to 
occm, particularly in an organ as well endowed with vascular 
anastomoses as the skin. Thus, grafts undergoing rejection, in 
contrast to the usual type of delayed skin reaction, must have 
a mechanism for intensifying vessel damage such t hat repara-
tive processes are overwhelmed, leading to vascular death and 
stasis of blood flow. A variety of possibilities may be considered, 
including among others more prolonged antigen stimulation 
and qualitative or quantitative differences in the pattern of 
lymphocyte mediator secretion. 
The data presented here suggest that vascularized graft re-
jection, though induced by immunologically specific mecha-
nisms, is primarily effected by final pathways that lead to 
damage of both foreign and host vessels and cells. This rather 
heretical viewpoint would seem at first blush to contradict one 
of the basic tenets of the graft rejection process; i.e., its exquisite 
specificity. For example, Billingham and colleagues [ 4] and 
Mintz and Silvers [15] employed donor grafts composed of a 
mixtme of genetically compatible and incompatible cells; com-
patible cells were commonly pigmented melanocytes which 
allowed subsequent positive identification in the recipient. In 
these experiments, at least some compatible cells generally 
smvived as judged by the persistence of pigmented skin and 
hair after the rejection of incompatible, nonpigmented skin. 
Critical examination of these data indicates that they do not, in 
fact, , contradict our findings. Smvival of compatible pigment 
cells in an otherwise incompatible graft may result from migra-
tion of such cells from the epidermis or superficial hair follicles 
of the donor skin to the transected hair follicles of the recipient 
in the graft bed [ 4]. Because melanocytes are capable of exten-
sive replication as well as migration, survival of only a small 
fraction of grafted compatible cells could permit the retention 
of substantial pigmented skin and hair following allograft rejec-
tion by a vessel damaging mechanism that did not itself discrim-
inate between foreign and compatible endothelial cells. Further, 
Mintz and Silvers [15] found that genetically compatible por-
tions of skin grafts generally did undergo nonspecific rej ection 
if foreign cells comprised a majority of the donor graft. Finally, 
we do not contend that microvascular damage leading to in-
farction is the only immunologic mechanism for rejecting for-
eign cells. Clearly allogeneic cells can be destroyed in a highly 
specific and discriminating fashion by direct cell contact with 
cytotoxic lymphocytes or by specific antibodies. While evidence 
for antibodies was lacking in om skin and tumor graft experi-
ments, scattered lymphocytes did infiltrate graft epidermis and 
appendages and apparently contributed to epithelial cell dy-
skeratosis; however, the contribution of this process to skin and 
tumor graft rejection appeared to be minor. Nonetheless, such 
an immunologically specific, lymphocyte-contact mechani m 
very likely accounts for the highly selective rejection of incom-
patible melanoblasts admixed within single hair follicles in 
grafts of allophenic mouse skin to parental strains [ 4,15]. 
In summary, allograft rejection may appa1·ently involve both 
highly specific and relatively nonspecific mechanisms operating 
separately or together, depending on such factors as the nature 
and antigenicity of the graft, its location, and whether or not it 
is vascularized. That multiple mechanism should exist for 
effecting the destruction of foreign cells is not smprising in view 
of the well-known heterogeneity of the immune response to 
relatively simpler and better defined antigens. Recognition of 
the critical role of immunologically mediated microvascular 
injury may prove important not only for an understanding of 
the biology of graft rejection but also for strategies aimed at 
prolonging survival of transplanted organ grafts and for hasten-
ing immunologically mediated tumor destruction. 
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DISCUSSION 
GREEN: What is needed is a bridge between the vast number 
of in vitro studies of cell-mediated cytotoxicity by a variety of 
cells and the elegant pictures that you have shown. More 
studies should be done with regard to the exact nature and 
function of the cells within these sections that are near the 
effete endothelial cells. This, I realize, is easier to say than to 
do! . 
DvoRAK: The problem is one of identifying appropriate ex-
periments. The in vitro work, as you say, has been done in 
isolation and it has served to identify the manifold potentialities 
of the lymphocyte, macrophage, etc. Indeed, the problem is not 
a lack of mechanisms by which target cells may be killed. If 
anything, in vitro studies have identified too many mechanisms! 
The problem is identifying which mechanisms are responsible 
in vivo for graft destruction. 
LEVIS: One prevalent viewpoint is a critical role for macro-
phages or RE-like cells playing a critical role in graft rejection. 
Lafferty and Talmage (Science 1976) have invoked this as an 
explanation for successful allografting of thyroid tissue follow-
ing in vitro maintenance. There is some evidence for mixed 
leukocyte culture activating determinants on endothelial cells. 
How do you see t he relationship of endothelial cells to this RE 
hypothesis? 
DvoRAK: I have no data on this point. 
GIGLI: Do you think that endothelial cell destruction may be 
platelet mediated? Although one may not find platelets at the 
site of injury, platelet factors may be released and produce 
cellular damage. 
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DvoRAK: It really has been consistently disappointing to us 
that we have not found platelets in either these reactions or in 
delayed type hypersensitivity reactions. The dogma has always 
been that when you get endothelial cell damage, you get sticky 
platelets that adhere to the vessel wall. In fact, in the presence 
of very extensive endothelial cell damage in delayed reactions 
and graft rejection, we see platelets sticking and we have 
consistently worried about missing them in some way. However, 
we cannot be simply missing them because in other circum-
stances we certainly have no trouble identifying platelets. We 
cannot, of course, rule out the possibility that a platelet factor 
is released and has a role in graft rejection. 
SoTER: In the skin allograft rejection study, the presence of 
infiltrating basophilic leukocytes, some of which were degran-
ulating, was noted. Would you comment on the integrity of the 
mast cells? 
DvoRAK: This is a very tough question, and one we did not 
study in depth. Mast cells in both allografts and autografts 
undergo early changes involving loss of granules. Very likely 
this is related to the trauma and ischemia of grafting. Whether 
these changes are greater in allografts than in autografts, I 
really do not know. 
WESTON : I was surprised by the absence of platelets and the 
infrequency of observed thrombosis in the face of severe endo-
thelial cell injury. What is your hypothesis to explain the 
sudden loss of blood flow that precedes the rejection of the 
graft? 
DvoRAK: Morphologists, as here, are often placed in the 
awkward position of telling what is happening without being 
able to tell why. With regard to the cessation of blood flow, one 
likely possibility is that loss of vascular integrity due to endo-
thelial cell damage, results in such extensive loss of plasma and 
cellular elements that pressure falls and circulation ceases. By 
analogy, multiple punctures in a garden hose lead eventually to 
cessation of flow. 
STREILEIN: Is the damage seen in vessels contributed by the 
host to the graft bed analogous to the vascular lesions seen in 
delayed hypersensitivity reactions? 
DvORAK: I would say that the damage in the 2 instances is 
qualitatively identical but, of course, severe in graft rejection 
than in delayed hypersensitivity. Whereas one vessel in 10 or 
20 might show changes of this type in a delayed hypersensitivity 
reaction, up to 80% of the vessels show this type of change here 
and it is progressive with time. 
STREILEIN: Concerning the lesions in vessels contributed by 
the graft, could. the target antigen in these vessels be expressed 
on macrophages (bone marrow derived cells) that assume an 
endothelial position in damaged vessels? 
DvORAK: That is a very interesting question but one on which 
I have n.o information. 
BRODY: Have you looked at the inflammatory infiltrate in 
Line 1 ascites tumors in guinea pigs very early after innocula-
tion-say 24-48 hr.? 
DvORAK: Yes we have, both in immune and nonimmune 
animals. In nonimmune animals there is a modest cellular 
infiltrate, mostly neutrophils with a few lymphocytes and a few 
monocytes. It really does not amount to very much. In the 
. immune animal, however, the tumor never becomes vascular-
ized and indeed is rejected within 40-80 hr, apparently by a 
contact mechanism involving lymphocytes. Lymphocytes sidle 
up to tumor cells and kill them. 
JORDON: At the beginning of the presentation, you mentioned 
that you used immunofluorescence in your study. Did you find 
immunoglobulin and/or complement deposition in the blood 
vessels? If so, did you perform time sequence studies of such 
deposition? 
DvORAK: We did not find deposits of immunoglobulin or 
complement, although we looked for both. 
CoHN: Have you looked at a second set of grafts on the same 
individuals? 
DvORAK: No, we have not . 
. 
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